References
Depfenhart, M., de Villiers, D., Lemperle, G., Meyer, M., & Di Somma, S. (2020). Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy? Internal and Emergency Medicine . doi:10.1007/s11739-020-02383-3
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., . . . Pöhlmann, S. (2020). SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. (1097-4172 (Electronic)).
Lucas, J. M., Heinlein, C., Kim, T., Hernandez, S. A., Malik, M. S., True, L. D., . . . Nelson, P. S. (2014). The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer Metastasis.Cancer Discovery, 4 (11), 1310. doi:10.1158/2159-8290.CD-13-1010
Lukassen, S., Chua, R. L., Trefzer, T., Kahn, N. C., Schneider, M. A., Muley, T., . . . Eils, R. (2020). SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells.The EMBO Journal, 39 (10), e105114. doi:10.15252/embj.20105114
Matsuyama, S., Nao, N., Shirato, K., Kawase, M., Saito, S., Takayama, I., . . . Takeda, M. (2020). Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proceedings of the National Academy of Sciences, 117 (13), 7001. doi:10.1073/pnas.2002589117
Shen, L. W., Mao, H. J., Wu, Y. L., Tanaka, Y., & Zhang, W. (2017). TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie, 142 , 1-10. doi:https://doi.org/10.1016/j.biochi.2017.07.016